WINTER 2020 I RETAIL/COMMUNITY • SPECIALTY • LTC
Stericycle’s Mail Back
and Take Back Solutions
Keep Businesses and
Communities Safe
Stericycle’s turnkey programs
support pharmacies in convenient
and compliant disposal of sharps
used in vaccinations and injectable
medications, as well as offer
pharmacy customers a safe method
for disposing expired or leftover
prescription medications.
page 43
WAY
CASE STUDY
www.cardinalhealth.com/MSIfranchise
PRIMARY INTENDED OUTCOME
Independent pharmacy is one of the most competitive markets in healthcare.
In any town or city, you’ll commonly fnd two (or more) competing big-name chain
pharmacies located on the same block, vying for consumer loyalty. Despite this intense
pressure, independent community pharmacies are not becoming a thing of the past.
Participants in this nearly $80 million sector simply need to work smarter in order to
rise above the noise. Co-branding with a larger, recognized organization is a tactical
approach to retaining a pharmacy’s independent identity, while benefting from a
powerful partnership.
Cardinal Health ofers independent pharmacies strategic co-branding opportunities
through their Medicine Shoppe International, Inc. franchise which leverages both
The Medicine Shoppe® and Medicap Pharmacy® national brands. Their value-added
business services support high performing independent pharmacy ownership and
provide the resources that can make community expansion possible.
THE CHALLENGE
The Tri-State Medical Group comprises three independent pharmacies located
in West Virginia and south eastern Ohio. “Our stores are within about 30 minutes
of each other, of diferent sizes, and in very diferent locations,” said J.J. Bernabei,
pharmacist and CEO/owner of Tri-State Medical. “Follansbee Pharmacy is in a strip
mall, Tri-State Pharmacy is in a medical building attached to a hospital, and Value
Leader Pharmacy is attached to a general practitioner and ob/gyn clinic.” All three
J.J. Bernabei
Pharmacist and CEO/Owner
~ Tri-State Medical, A member of
The Medicine Shoppe® Family
How a strategic partnership can
lead to operational efciencies for
independent pharmacies.
The Advantages of Co-Branding With
Medicine Shoppe International, Inc.
Case Study:
The Advantages of
Co-Branding With
Medicine Shoppe
International, Inc.
How a strategic partnership
can lead to operational
efficiencies for independent
pharmacies.
WAY
My Pharmacy. My Patients. MyEncore.Life
Professional Grade CBD
Formulated by pharmacists, for pharmacists
Call 888.673.2729 for 15% of your first order!
888.673.2729
info@myencore.life
www.myencore.life
From ingredient selection to our multi-level testing pro-
cess, every choice we make ensures you receive a pure,
consistent, top quality product every time you order.
Don’t take our word for it - hear what our practitioners
have to say at myencore.life/practitioners.
100% Practitioner
Exclusive CBD by
Encore Life
Leading the way in quality,
delivering premium value to
our customers, and driving
growth through business and
educational support.
page 41
w w w. a c c i u s a . c o m • 8 8 8 . 3 9 5 . 2 2 2 1
ACC combines robust reagents, analysis and
technical service expertise, to provide you with diverse
solutions for endotoxin and glucan testing.
Associates of Cape Cod, Inc.
Your Endotoxin & Glucan Experts
OUR TEST, YOUR CURE...
ENSURING A HEALTHY WORLD
ENSURING A HEALTHY WORLD
The Pyrosate® Kit
by Associates of
Cape Cod Delivers
Rapid Endotoxin
Testing Results
for Compounding
Pharmacies
Pyrosate® has been developed as
an easy-to-use Limulus Amebocyte
Lysate (LAL) gel-clot test that
enables rapid testing and does not
require special laboratory supplies.
page 39
WAY
Yuyama’s Quiet and
Intelligent Litrea III
Pouch/Compliance
Packaging Automation
The robustness and versatility
of the quiet Litrea III will deliver
you accuracy, speed, and
technician relief in addition
to saving you money and time.
Your silent partner in success!
page 33
WAY
Contents
page 34-37
Welcome to the
Higher Level...
The Finest Organic Full Spectrum Colorado Grown
Hemp CBD Products on the Market
tinctures | capsules | topicals | beauty | vapes | gummies | pet products
844.TO.IMBUE
(844.864.6283)
www.imbuebotanicals.com
products available today.
Exquisitely packaged to enhance our lifestyle image, and backed by an industry-leading comprehensive training
and support program, Imbue products add exceptional value to any retail pharmacy settings. Wholesale
opportunities available. Call, or visit our website TODAY!
Imbue Botanicals –
The Most Extensive,
Clinically Efficacious
CBD Product
Line Available
Imbue Botanicals offers the
most extensive line of premium,
clinical-grade CBD products,
including tinctures, capsules,
and topical lotions and salves,
all available in multiple strengths
for people and pets.
page 45
CANNABIDIOL (CBD) RESOURCES & PRODUCTS
WAY
page 46-49
CANNABIDIOL (CBD)
RESOURCES & PRODUCTS
Buyer’s Guide
WINTER 2020 I RETAIL/COMMUNITY • SPECIALTY • LTC
34
CANNABIDIOL (CBD) RESOURCES & PRODUCTS Buyer’s Guide
Ananda Professional
1961 S. Edgewater Road
Cynthiana, KY 41031
(888) 388-1119
Anandaprofessional.com
CBDistillery
1720 S Bellaire Street, Penthouse
Denver, CO 80222
(855) 223-7766
www.thecbdistillery.com
Encore Life
805 W. New Orleans Street
Broken Arrow, OK 74011
(800) 454-2304
www.myencore.life
Im-Bue Botanicals
870 East Research Drive, #4
Palm Springs, CA 92262
(844) 864-6283
imbuebotanicals.com
Letco Medical
460 E. Swedesford Road #2040
Wayne, PA 19087
(800) 378-0009
www.letcocbd.com
Medella Sciences
6930 Signat Drive
Houston, TX 77041
Medellasciences.com
Medterra
9801 Research Drive
Irvine, CA 92618
(800) 971-1288
medterracbd.com
PlusCBD™ Oil by CV Sciences
10070 Barnes Canyon Road
San Diego, CA 92121
(855) PLUS-CBD (758-7223)
www.pluscbdoil.com
PRS Pharmacy Services
P.O. Box 852, 201 Depot Street
Suite 200
Latrobe, PA 15650
(800) 338-3688
www.prsrx.com
Uleva
1770 Blake Street
Denver, CO 80202
(720) 577-4448
uleva.com
Industry Expert Q&A,
Cannabidiol (CBD) Resources
and Products Market Leaders
Buyer’s Guide, and more.
Q A
WINTER 2020 I RETAIL/COMMUNITY • SPECIALTY • LTC
CANNABIDIOL (CBD) RESOURCES & PRODUCTS Q&A
46
Anthony J, Calamunci, Esq., FisherBroyles
Q. Is CBD a pain management alternative
to opioids?
CBD or cannabinoid itself is non-psychoactive. Preliminary
research indicates CBD or cannabidiol could be a successful
opioid alternative. Recent studies have shown that states with
medical marijuana laws (THC and CBD) have twenty-five
percent (25%) fewer opioid-related deaths than states that
have not implemented laws. Studies also show that CBD has
a diminishing effect on drug cravings, which could impact
the high relapse rates associated with opioids. While some
studies are encouraging, it’s also important to understand
why CBD shows so much promise to fight the opioid
crisis. Education is key as CBD or cannabidiol continues
to emerge as a pain management solution. CBD offers an
opioid alternative for the treatment of chronic pain. Just
last year, a study from the European Journal of Pain showed
that (using an animal model) CBD applied on the skin could
help lower pain and inflammation due to arthritis.[1]
Q. Will CBD alone get a patient high?
No. Scientifically and clinically, hemp plants contain less
than 0.3% tetrahydrocannabinol (“THC”), the psychoactive
chemical found in cannabis. This minute amount of THC
will not make a patient feel high, reducing the risks of theft,
addiction, and diversion associated with THC use.
Q. What is the FDA position on CBD?
To date, only one prescription medication containing CBD
has been approved by the FDA – Epidiolex, a drug used to
treat some forms of epilepsy. The FDA has historically issued
several warning letters to firms that market unapproved
new drugs that allegedly contain cannabidiol (CBD).
Interestingly, the FDA has tested the chemical content of
cannabinoid compounds in some of the products and many
were found to not contain the levels of CBD they claimed
to contain. CBD products are not approved by FDA for
the diagnosis, cure, mitigation, treatment, or prevention
of any disease. Notices and warnings related to promised
outcomes of the effectiveness of CBD products should be
considered before promoting or offering any CBD product
for sale.[2] The FDA held its first public hearing on how
regulation should be implemented on May 31, 2019 and in
the future will regulate CBD products. The goal of the May
2019 public hearing was for the FDA to learn about the
current status of the safety, manufacturing, product quality,
marketing, labeling, and sale of products containing CBD.
Q. How do you know what’s in the bottle
labeled CBD?
Currently the manufacturing of CBD is unregulated.
According to the Centers for Disease Control (CDC),
synthetic products marketed as CBD sickened at least 52
people in Utah last winter, sending 31 of them to emergency
rooms.[3] This lack of regulatory oversight creates a certain
level of ongoing risks.
Q. Why CBD or cannabidiol?
Many patients have reported pain management success
when using CBD products. As research on CBD products
and effects continues, owners must continue to monitor
published research to determine if the CBD products
offered remain safe and beneficial.[4] To date, there is no
recognized research to support CBD products for use as an
appropriate treatment for serious medical conditions like
cancer, diabetes, and Alzheimer’s disease. However, CBD
is commonly used to address anxiety and insomnia, with
some supportive research for these ailments.
CANNABIDIOL (CBD)
RESOURCES & PRODUCTS
NCPA CBD Source
Powered by PRS
CBD education and quality
product selection by
pharmacists for pharmacists!
page 51
WAY
CANNABIDIOL (CBD) RESOURCES & PRODUCTS
CANNABIDIOL (CBD) RESOURCES & PRODUCTS